HCC vs. healthy subjects: 90.3%/90.2%; 0.949HCC vs. CLD: 59.7%/78.4%; 0.705cfDNA + AFP (HCC vs. healthy subjects): 95.1%/94.4%; 0.974. This evidence concerns the gene AFP and hepatocellular carcinoma.